These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6509251)

  • 1. Immunization against leprosy: progress and prospects.
    Noordeen SK; Sansarricq H
    Bull Pan Am Health Organ; 1984; 18(3):295-99. PubMed ID: 6509251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization against leprosy: progress and prospects.
    Noordeen SK; Sansarricq H
    Bull World Health Organ; 1984; 62(1):1-6. PubMed ID: 6370487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
    Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative leprosy vaccine trial in south India.
    Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
    Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report.
    Job CK; Sanchez RM; Hunt R; Truman RW; Hastings RC
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):394-7. PubMed ID: 8228437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.
    Convit J; Sampson C; Zúñiga M; Smith PG; Plata J; Silva J; Molina J; Pinardi ME; Bloom BR; Salgado A
    Lancet; 1992 Feb; 339(8791):446-50. PubMed ID: 1346818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine development. On relating immunology to the Third World: some studies on leprosy.
    Bloom BR; Salgame P; Mehra V; Kato H; Modlin R; Rea T; Brennan P; Convit J; Lugozi L; Snapper S
    Immunol Suppl; 1989; 2():87-9; discussion 91-2. PubMed ID: 2680926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination and skin test studies on the children of leprosy patients.
    Stanford JL; Stanford CA; Ghazi Saidi K; Dowlati Y; Weiss SF; Farshchi Y; Madlener F; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):38-44. PubMed ID: 2659700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
    Janaszek W
    Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam.
    Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.